Johnson & Johnson Halts COVID-19 Vaccine Study After Participant Comes Down With 'Unexplained Illness'
Published
The clinical trial involves 60,000 patients.
Full ArticlePublished
The clinical trial involves 60,000 patients.
Full ArticleWatch VideoFor Elizabeth Power of Nebraska, like so many parents in this pandemic, the well-being of her three children is most..
Watch VideoThe race for an approved COVID-19 vaccine is dealing with a setback. Johnson & Johnson has paused their late stage..